Management of Dyslipidemia

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author Amber E. Johnson, MD, MS, MBA, of the University of Chicago joins JAMA Senior Editor Philip Greenland, MD, to discuss the ACC/AHA guideline on management of dyslipidemia. Related Content: Dyslipidemia Evaluation and Management https://jamanetwork.com/journals/jama... Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy https://jamanetwork.com/journals/jama... Podcast was originally published on July 20, 2026. https://edhub.ama-assn.org/jn-learnin... --------------------------------------------------------------------------------- Follow JAMA Clinical Reviews on: Youtube:    • JAMA Clinical Reviews   Apple Podcasts: https://podcasts.apple.com/us/podcast... Spotify: https://open.spotify.com/show/229VuDi... Pocket Casts: https://pca.st/3ghw Your podcast app of choice: https://pod.link/1027430378 Website: https://jamanetwork.com/journals/jama... --------------------------------------------------------------------------------- For more from JAMA • https://www.jama.com •   / jamajournal   •   / jama_current   •   / jamanetwork   Follow the JAMA Network • https://www.jamanetwork.com • http://www.jamanetworkaudio.com •   / jamanetwork   •   / jamanetwork   •   / jamanetwork   •   / jamanetwork